$1,148.00
▼ -0.1% Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 24
▼ 0
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound?
Great News for Eli Lilly Stock Investors
What Does Eli Lilly (LLY) Gain From Its $2.88 Billion Immunology Deal?
Overview
52-week range
$712
$1.3K
75% of range
Avg surprise (last 2)
+3.7%
Avg reaction (last 1)
-11.7%
0% positive
Latest IV / EM
34%
EM ±1.4% · $1160 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $7.94 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $8.26 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $6.21 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $6.31 | $5.61 | +12.5% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $3.34 | $3.52 | -5.1% | — | -11.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.07 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $3.28 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $2.48 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.06 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.95 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $1.49 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.97B | $19.80B | — | $17.60B | $15.56B | $12.73B | — | $11.44B |
| Cost of revenue | $3.27B | $3.58B | — | $3.01B | $2.45B | $2.23B | — | $2.17B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $7.09B | $7.40B | — | $5.58B | $5.66B | $2.76B | — | $970M |
| EPS (diluted) | $7.94 | $8.26 | — | $6.21 | $6.29 | $3.06 | — | $1.07 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.95B | $5.28B | $7.27B | $9.79B | $3.38B | $3.09B | $3.27B | $3.37B |
| Inventory | $16.79B | $14.53B | $13.74B | $12.18B | $11.01B | $9.31B | $7.59B | $7.46B |
| Total current assets | $64.67B | $54.84B | $55.63B | $62.07B | $49.85B | $41.26B | $32.74B | $31.42B |
| Total assets | $142.28B | $116.58B | $112.48B | $114.94B | $100.92B | $89.39B | $78.71B | $75.61B |
| Long-term debt | $47.86B | $39.37B | $40.87B | $40.87B | $34.18B | $34.50B | $28.53B | $29.05B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $33.88B | $31.20B | $26.54B | $23.79B | $18.27B | $15.76B | $14.19B | $14.24B |